Minimal clinically important difference of the Brief-BESTest in COPD

C. Paixão (Guarda, Portugal), P. Rebelo (Guarda, Portugal), A. Oliveira (Toronto, Canada), C. Jácome (Porto, Portugal), J. Cruz (Leiria, Portugal), V. Martins (Figueira da Foz, Portugal), P. Simão (Matosinhos, Portugal), A. Marques (Aveiro, Portugal)

Source: Virtual Congress 2020 – Aspects of pulmonary rehabilitation: part 1
Session: Aspects of pulmonary rehabilitation: part 1
Session type: E-poster session
Number: 2935
Disease area: Airway diseases

Congress or journal article abstractE-poster

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
C. Paixão (Guarda, Portugal), P. Rebelo (Guarda, Portugal), A. Oliveira (Toronto, Canada), C. Jácome (Porto, Portugal), J. Cruz (Leiria, Portugal), V. Martins (Figueira da Foz, Portugal), P. Simão (Matosinhos, Portugal), A. Marques (Aveiro, Portugal). Minimal clinically important difference of the Brief-BESTest in COPD. 2935

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Minimal clinically important difference of the clinical COPD questionnaire
Source: Eur Respir J 2004; 24: Suppl. 48, 689s
Year: 2004

Minimal clinically important difference and predictive validity of the mMRC and mBorg in acute exacerbations of COPD
Source: International Congress 2017 – Assessing functional outcomes in chronic respiratory disease
Year: 2017


Minimal important difference of change in patient-specific goals in severe emphysema patients
Source: ERJ Open Res, 6 (4) 00459-2020; 10.1183/23120541.00459-2020
Year: 2020



Responsiveness and minimal clinically important difference of K-BILD and SGRQ-I
Source: Virtual Congress 2020 – Clinical aspects of idiopathic pulmonary fibrosis
Year: 2020


The Severe Asthma Questionnaire: sensitivity to change and minimal clinically important difference
Source: Eur Respir J, 57 (6) 2100300; 10.1183/13993003.00300-2021
Year: 2021



Minimal clinically important difference for asthma endpoints: an expert consensus report
Source: Eur Respir Rev, 29 (156) 190137; 10.1183/16000617.0137-2019
Year: 2020



Minimal important difference for the asthma control questionnaire
Source: Eur Respir J 2004; 24: Suppl. 48, 460s
Year: 2004

Minimal clinically important difference in idiopathic pulmonary fibrosis
Source: Breathe, 17 (2) 200345; 10.1183/20734735.0345-2020
Year: 2021



Minimal clinically important difference in 30 second sit-to-stand test after pulmonary rehabilitation in patients with COPD
Source: International Congress 2018 – Latest advances in pulmonary rehabilitation assessment and content
Year: 2018



Minimal clinically important difference using one-repetition maximum in COPD
Source: International Congress 2019 – Insights into assessment of functional status in respiratory disease patients
Year: 2019


Minimal clinically important difference for measures of fatigue, cough and sputum
Source: International Congress 2019 – Insights into assessment of functional status in respiratory disease patients
Year: 2019

Minimal clinically important difference for daily pedometer step count in COPD
Source: ERJ Open Res, 7 (1) 00823-2020; 10.1183/23120541.00823-2020
Year: 2021



The minimal clinically important difference of the Severe Respiratory Insufficiency questionnaire in severe COPD
Source: Eur Respir J, 56 (6) 2001334; 10.1183/13993003.01334-2020
Year: 2020



The Severe Asthma Questionnaire (SAQ) - minimal clinically important difference and sensitivity to change
Source: Virtual Congress 2021 – Patient-reported outcome measures (PROMs): easy tools in the management of chronic respiratory diseases
Year: 2021



The 4-metre gait speed in COPD: responsiveness and minimal clinically important difference
Source: Eur Respir J 2014; 43: 1298-1305
Year: 2014



Clinically meaningful improvements with reslizumab in patient-reported outcomes and lung function in a sub-population defined by the EU indication with =3 exacerbations
Source: International Congress 2017 – Asthma: mechanisms and treatment
Year: 2017


The minimal clinically important difference of the Severe Respiratory Insufficiency questionnaire.
Source: International Congress 2018 – Non-invasive ventilation in chronic respiratory failure
Year: 2018

Long-term outcome following first clinically important deterioration in COPD
Source: International Congress 2016 – Pharmacological management of COPD
Year: 2016


Responsiveness and minimum clinically important difference of the 4 metre gait speed in chronic obstructive pulmonary disease
Source: Annual Congress 2013 –The best abstracts in pulmonary rehabilitation and chronic care (sponsored by MOTEK Medical)
Year: 2013


The impact of patient characteristics on the Minimal Clinically Important Difference of COPD health status tools
Source: International Congress 2018 – Respiratory epidemiology: from COPD to factors that associate with lung function and infections
Year: 2018